CAD 0.62 AIDX.TO Healwell AI (TSX) intraday 23 Feb 2026: cautious AI play
AIDX.TO stock is trading at CAD 0.62 intraday on TSX on 23 Feb 2026. The share sits near its 52-week low of CAD 0.62 and is down 62.20% year-over-year. Volume is moderate at 492,212.00 shares as investors weigh Healwell AI Inc.’s AI strategy against weak cash flow and negative EPS of -0.23. We track technical oversold signals and model-based forecasts to frame risk and a possible tactical trade.
AIDX.TO stock intraday snapshot and price action
Healwell AI Inc. (AIDX.TO) trades on the TSX at CAD 0.62 with a day range of CAD 0.62 to CAD 0.63. One trading fact: the 50-day average is CAD 0.85 and the 200-day average is CAD 1.22, signalling longer-term weakness. Volume today is 492,212.00 versus an average of 501,770.00, showing near-normal liquidity.
AIDX.TO stock financials and valuation
Healwell AI reports EPS of -0.23 and a negative PE ratio of -2.70, which reflects losses. Price-to-sales is 1.72 and price-to-book is 1.23, suggesting the market values growth potential above current profitability. Current ratio is 0.85, and cash per share is 0.07, which point to tight short-term liquidity for a company investing in AI development.
AIDX.TO stock technicals and trading signals
Technically AIDX.TO stock reads oversold. The RSI is 26.78, MACD histogram is -0.01, and ADX at 37.90 shows a strong downtrend. Bollinger Bands are 0.55 to 0.94, placing current price near the lower band. Traders may view short-term bounces, but momentum and ROC at -23.46% favour lower prices until cash-flow or revenue surprises arrive.
AIDX.TO stock Meyka AI grade and model forecasts
Meyka AI rates AIDX.TO with a score of 54.10 out of 100 (Grade C+, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly CAD 0.41, quarterly CAD 0.56, and yearly CAD 0.43. Compared to the current CAD 0.62, the yearly model implies a downside of -30.58%. Forecasts are model-based projections and not guarantees.
AIDX.TO stock growth drivers, partnerships and risks
Healwell AI’s core product is an AI-enabled decision support platform for preventative care and a strategic alliance with WELL Health Technologies Corp. could drive revenue expansion. A single claim: revenue per share is 0.42, but free cash flow per share is negative at -0.11, so growth depends on successful commercialization and margin improvement. Major risks include low current liquidity, negative operating margins of -1.06, and long receivable days at 135.18.
AIDX.TO stock sector context and relative performance
Healwell AI sits in the broader Canadian healthcare and AI tech mix on TSX, where sector peers show varied fundamentals. The healthcare sector has weak YTD performance at -2.92%, making Healwell’s declines of -26.19% YTD more pronounced. Investors should compare AIDX.TO stock metrics to larger tech and health names when sizing positions.
Final Thoughts
Key takeaways on AIDX.TO stock: the intraday price is CAD 0.62 on TSX on 23 Feb 2026, trading near its 52-week low with volume at 492,212.00. Fundamentals show negative EPS -0.23, weak operating margins, and tight liquidity, while technicals are oversold. Meyka AI’s forecast model projects a yearly price of CAD 0.43, implying a -30.58% downside versus the current level. Realistic price targets: a conservative near-term target of CAD 0.40 and an optimistic recovery target of CAD 1.20 if revenue growth and cash flow improve. Remember, this is market analysis only. Use risk controls and monitor the earnings update on 2026-03-26. Meyka AI provides this AI-powered market analysis to inform your view but not as investment advice.
FAQs
What is the current price and market cap of AIDX.TO stock?
AIDX.TO stock trades at CAD 0.62 intraday on TSX with a market cap of approximately CAD 172,606,616.00. Volume today is 492,212.00, near its average daily liquidity.
What do forecasts and models say about AIDX.TO stock?
Meyka AI’s forecast model projects a yearly price of CAD 0.43 for AIDX.TO stock, implying a downside of about -30.58% from today. Forecasts are model-based and not guarantees.
What are the main risks for AIDX.TO stock investors?
Primary risks for AIDX.TO stock include negative EPS (-0.23), low current ratio (0.85), negative operating margins, and long receivables at 135.18 days. Execution on commercial deals is critical.
When is Healwell AI’s next earnings report and why does it matter?
Healwell AI’s next earnings announcement is scheduled for 2026-03-26. That report should clarify revenue traction, cash flow trends, and whether AI partnerships are converting to recurring sales, which will affect AIDX.TO stock volatility.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.